Study of prediction of response to pegylated interferon plus ribavirin in hepatitis C patients by IL28B gene variation and its relation to other different predictors

Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

Some potential genetic markers for prediction of treatment response in HCV affected Egyptian children

Serum Level of interferon γ inducible protein 10 (IP-10) as a predictor of response to treatment with peg-interferon plus ribavirin in egyptian chronic HCV patients

The clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin

Single nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children

INTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C.

Sustained virological response rate to combined antiviral therapy in adult Egyptian patients with histologically mild chronic hepatitis C

Interleukin 28B Polymorphism as a Predictor of Response to Treatment of Egyptian HCV Patients Working in Nuclear Material Authority

Hepatitis C virus infection in Egyptian patients w